ANIP Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jul 2024 @ 19:20):
Our systems believe the stock currently is undervalued by 0.11% compare to its pairs and should correct upwards.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada...

Stats
Dagens volum	55 278
Gjennomsnittsvolum	159 235
Markedsverdi	1.32B
EPS	$0.840 ( Q1 \| 2024-05-10 )
Neste inntjeningsdato	( $0 ) 2024-08-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	39.07 (Sector) 42.63 (Industry) 0
ATR14	$0.0850 (0.14%)

ACOR -24.02%

ACRX 7.50%

ADMP 0.85%

ADMS 0.00%

AGRX 0.71%

AKAN -1.69%

ALIM -0.63%

AMPH -4.03%

AMYT 0.00%

ANIP -1.22%

AQST -6.73%

ASRT 0.43%

ATNX 0.00%

AVDL -1.88%

AYTU -1.41%

BFRI -0.89%

BGXX 8.34%

CLVR 0.00%

COLL 0.93%

CPIX -1.31%

CRDL -1.49%

CRON -1.51%

CYTH -3.40%

DCPH 0.00%

DERM -4.43%

DRRX 1.55%

DVAX -0.67%

EGRX -4.11%

EMBC -2.00%

EMBCV -9.33%

EOLS 1.94%

ESPR 7.71%

EVOK -4.54%

FLGC -1.97%

FLXN 0.00%

GHSI -1.68%

HCM 3.10%

HROW 0.67%

HUGE -3.75%

IMCC -3.96%

INCR 1.99%

IRWD 0.39%

ITCI -2.41%

IXHL 0.34%

JUPW 11.76%

KALA -4.23%

KIN 0.11%

KMDA -1.20%

LNTH -0.22%

NBIX 1.30%

NEPT 0.00%

NLTX 1.45%

OGI 0.97%

OPTN 0.96%

ORGO -2.67%

PAHC 1.91%

PCRX 0.49%

PETQ 0.63%

PLXP 0.00%

PPD 0.00%

PROC -0.32%

PRPH -2.63%

PTPI -1.92%

RDHL -0.05%

RDUS 0.59%

REPH -0.48%

RGC -5.03%

RMTI -2.84%

SCTL 0.92%

SCYX -3.75%

SIGA -1.84%

SISI -14.34%

SNDL 0.53%

SNOA 2.64%

SSIC -2.87%

SUPN -1.51%

SXTC 0.94%

THTX 0.30%

TKNO -8.76%

TLGT -13.85%

TLRY 1.20%

TXMD 3.11%

TYHT -3.90%

UPC 3.75%

VTRS -0.59%

ZYNE 2.36%

Insider Trading

Date	Person	Action	Amount	type
2024-06-21	Shanmugam Muthusamy	Sell	20 000	Common Stock
2024-06-17	Shanmugam Muthusamy	Sell	7 946	Common Stock
2024-06-18	Shanmugam Muthusamy	Sell	10 607	Common Stock
2024-06-20	Shanmugam Muthusamy	Sell	11 447	Common Stock
2024-06-13	Cook Meredith	Sell	250	Common Stock

INSIDER POWER
-27.42
Last 100 transactions
Buy: 371 183 \| Sell: 622 427

Korrelasjon (AI algo v.1.1b): Undervalued: 0.11% $62.97 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: 0.07 (neutral)

Kort: -0.77 (moderate negative)

Signal:(36.605) Neutral

ANI Pharmaceuticals Inc Korrelasjon

10 Mest positive korrelasjoner
OZEM	1
REBN	0.944
MMUKX	0.94
TRVI	0.937
KARRX	0.937
PRUAX	0.933
PRUZX	0.933
FIUIX	0.932
NALFX	0.927
BDGS	0.927

10 Mest negative korrelasjoner
SABR	-0.95
MFIN	-0.928
CYAN	-0.924
CLMB	-0.917
SOFO	-0.912
DPRO	-0.905
BRLSW	-0.904
AMCX	-0.9
ACON	-0.898
AAPD	-0.896

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

ANI Pharmaceuticals Inc Korrelasjon - Valuta/Råvare

0.56
( weak )

0.17
( neutral )

0.00
( neutral )

0.03
( neutral )

-0.24
( neutral )

-0.20
( neutral )

ANI Pharmaceuticals Inc Økonomi

Annual	2023
Omsetning:	$486.82M
Bruttogevinst:	$245.51M (50.43 %)
EPS:	$0.950

FY	2023
Omsetning:	$486.82M
Bruttogevinst:	$245.51M (50.43 %)
EPS:	$0.950

FY	2022
Omsetning:	$316.39M
Bruttogevinst:	$177.60M (56.13 %)
EPS:	$-2.95

FY	2021
Omsetning:	$216.14M
Bruttogevinst:	$115.53M (53.45 %)
EPS:	$-5.81

Financial Reports:

No articles found.

ANI Pharmaceuticals Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.